DCM Foundation
Heartfelt Thanks
to our Sponsors

Sign Up for Regular
DCM Updates

Blog

Clinical Trial Now Enrolling for Patients with Genetic DCM (MYH7)

Dilated cardiomyopathy, DCM, has many causes and can be acquired or genetic. Genetic means a disease-causing change, or “mutation”, has occurred in a relevant gene. That mutation may have occurred in prior generations or may be new as just having happened in a patient 1,2. This type of DCM is called genetic DCM.   Research

Read More… from Clinical Trial Now Enrolling for Patients with Genetic DCM (MYH7)

First DCM Patient and Family Conference – a Great Success

The first-ever DCM Patient and Family Conference was held virtually on September 24, 2022. This well-attended event included 3 sessions: DCM Education, The Latest in DCM Research and Therapies, and Patient Panel Discussions. (See below for recording links.) We would like to give special thanks to all the DCM patients and family members who registered

Read More… from First DCM Patient and Family Conference – a Great Success

New Potential Targets for Gene Therapy in Heart Failure Patients

New targets for gene therapy may have been identified by researchers at Harvard Medical School and Brigham and Women’s Hospital. They studied the specific cell changes that lead to heart failure diseases like dilated cardiomyopathy. “Our findings hold enormous potential for rethinking how we treat heart failure and point to the importance of understanding its

Read More… from New Potential Targets for Gene Therapy in Heart Failure Patients

Connect with us!
Facebook Instagram Twitter YouTube LinkedIn

Contact Us

1-833-DCM-HOPE
(1-833-326-4673)

7826 Kate Brown Drive
Dublin, Ohio 43017

Info@DCMFoundation.org